Home |
Free Dividend Report |
Stock Splits Calendar |
ANTX Historical Stock Prices |
Preferred Stock Newsletter |
Top Option Ideas |
Stock Message Boards |
AN2 Therapeutics (ANTX) has the following price history information. Looking back at ANTX historical stock prices for the last five trading days, on April 17, 2024, ANTX opened at $2.48, traded as high as $2.51 and as low as $2.43, and closed at $2.48. Trading volume was a total of 87.50K shares. On April 18, 2024, ANTX opened at $2.48, traded as high as $2.52 and as low as $2.36, and closed at $2.38. Trading volume was a total of 145.40K shares. On April 19, 2024, ANTX opened at $2.48, traded as high as $2.48 and as low as $2.40, and closed at $2.47. Trading volume was a total of 101.60K shares. On April 22, 2024, ANTX opened at $2.49, traded as high as $2.50 and as low as $2.36, and closed at $2.36. Trading volume was a total of 116.30K shares. On April 23, 2024, ANTX opened at $2.36, traded as high as $2.42 and as low as $2.31, and closed at $2.37. Trading volume was a total of 83.10K shares.
ANTX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AN2 Therapeutics shares, starting with a $10,000 purchase of ANTX, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 03/25/2022 | |
End date: | 04/23/2024 | |
Start price/share: | $15.40 | |
End price/share: | $2.37 | |
Dividends collected/share: | $0.00 | |
Total return: | -84.61% | |
Average Annual Total Return: | -59.29% | |
Starting investment: | $10,000.00 | |
Ending investment: | $1,539.30 | |
Years: | 2.08 |
ANTX Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
04/17/2024 | $2.48 | $2.51 | $2.43 | $2.48 | 87.50K |
04/18/2024 | $2.48 | $2.52 | $2.36 | $2.38 | 145.40K |
04/19/2024 | $2.48 | $2.48 | $2.40 | $2.47 | 101.60K |
04/22/2024 | $2.49 | $2.50 | $2.36 | $2.36 | 116.30K |
04/23/2024 | $2.36 | $2.42 | $2.31 | $2.37 | 83.10K |
About AN2 Therapeutics |
AN2 Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel medicines for patients with rare infectious diseases. Co.'s initial product candidate, epetraborole, an antibiotic under development as a once-daily, oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. |
ANTX Historical Closing Prices | |
Date | Close |
04/17/2024 | $2.48 |
04/18/2024 | $2.38 |
04/19/2024 | $2.47 |
04/22/2024 | $2.36 |
04/23/2024 | $2.37 |
Financials Historical Prices |
ANTX is categorized under the Financials sector; below are some other companies in the same sector:
AOA Historical Stock Prices
Free ANTX Email Alerts:
|
ANTX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.